NOVEL THERAPIES FOR CANCER
The invention relates to 6-{4-[1 -(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1 -yl}-N- (pyridin-4-yl)pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof, for use in treatment of CNS cancers. The invention also relates to combination treatments with irradiation and/or a chemotherapeu...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
06.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to 6-{4-[1 -(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1 -yl}-N- (pyridin-4-yl)pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof, for use in treatment of CNS cancers. The invention also relates to combination treatments with irradiation and/or a chemotherapeutic agent for use in the treatment of cancer
L'invention concerne 6-{4-[1-(propane-2-yl)pipéridine-4-yl]-1,4-diazépan-1 -yl}-N-(pyridine-4-yl)pyridine-2-carboxamide, ou un sel pharmaceutiquement acceptable de celui-ci, pour une utilisation dans le traitement de cancers du système nerveux central. L'invention concerne également des polythérapies faisant intervenir les rayons et/ou un agent de chimiothérapie pour une utilisation dans le traitement du cancer. |
---|---|
Bibliography: | Application Number: CA20162979167 |